President Strategic Consulting

Envision Pharma Group appoints Tom Langan as Chief Executive Officer

Dermatological Drugs Market Forecast to 2034 – For Business Leaders, Analysts, and Strategic Teams

Sol-Gel Technologies Ltd. (SLGL) sells U.S. rights for EPSOLAY and TWYNEO

Mayne Pharma Served With Legal Proceeding Filed Against One Of Its US Subsidiaries

Gross-to-Net Analyst

Envision Pharma Group is a company dedicated to creating life-changing outcomes through their work with clients and community involvement. They are seeking a detail-oriented Gross to Net (GTN) Analyst to analyze financial data and create models to assess client profitability, ultimately driving strategic business decisions and improving financial performance.

Sign up with Google

Sign in with Google